OpenVSafe by OpenVAERS
Search V-safe

5MZ-14996-09484

2 vaccinations 2 coded responses 24 check-ins 2 free-text entries 1 call case
Sex
Female
Age at first dose
0-4
ZIP prefix
223 / VA
Registered
2022-09-24
Relationship
Child or adolescent in my care
Guardian
K2X-19993-09825
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2022-09-23
    Dose 1 — Moderna
  2. 2022-09-24
    Registered in v-safe
  3. 2022-09-24
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · Sleepiness
    Under 3 check-in
  4. 2022-09-25
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Fair · Fever · Loss of appetite
    Under 3 check-in
  5. 2022-09-26
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  6. 2022-09-27
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  7. 2022-09-28
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  8. 2022-09-29
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  9. 2022-09-30
    Health check-in — day 7, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  10. 2022-10-07
    Health check-in — day 14, dose 1, under 3
    Feeling: Good
    Under 3 check-in
  11. 2022-10-14
    Health check-in — day 21, dose 1, under 3
    Feeling: Good
    Under 3 check-in
  12. 2022-10-21
    Survey response — day 28, dose 1, under 3
    MedDRA: Respiratory syncytial virus infection — Feeling: Fair · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: RSV
    MedDRA releases: 2024-11 · check-in free text available
  13. 2022-10-21
    Report sent to call center — day 28, dose 1, under 3
    Be unable to work or attend school · Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  14. 2022-10-24
    Call successful
    Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
  15. 2022-10-28
    Dose 2 — Moderna
  16. 2022-10-29
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Fair · Sleepiness
    Under 3 check-in
  17. 2022-10-30
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Good · Sleepiness
    Under 3 check-in
  18. 2022-10-31
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  19. 2022-11-01
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  20. 2022-11-02
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  21. 2022-11-03
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  22. 2022-11-04
    Health check-in — day 7, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  23. 2022-11-11
    Health check-in — day 14, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  24. 2022-11-18
    Survey response — day 21, dose 2, under 3
    MedDRA: Respiratory syncytial virus infection — Feeling: Fair · Be unable to work or attend school
    Free text: RSV
    MedDRA releases: 2024-11 · check-in free text available
  25. 2022-11-25
    Health check-in — day 28, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  26. 2022-12-02
    Health check-in — day 35, dose 2, under 3
    Feeling: Fair
    Under 3 check-in
  27. 2022-12-09
    Health check-in — day 42, dose 2, under 3
    Feeling: Fair
    Under 3 check-in
  28. 2023-01-27
    Health check-in — 3 months, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  29. 2023-04-28
    Health check-in — 6 months, dose 2, under 3
    Feeling: Good
    Under 3 check-in

Vaccinations

DoseDateManufacturerCo-administered
12022-09-23Moderna No
22022-10-28Moderna No

Call center

1 call center case

1 successful

See the call center timeline

Free text

Release 12 (Under 3) — day 28, dose 1, under 3

2022-10-21

Symptoms: RSV

Release 12 (Under 3) — day 21, dose 2, under 3

2022-11-18

Symptoms: RSV

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDRespiratory syncytial virus infection · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…